Effect of a low dose of empagliflozin on short-term outcomes in type 2 diabetics with acute coronary syndrome after percutaneous coronary intervention

OBJECTIVES: To study the effects of low dose of empagliflozin on improving outcomes in diabetic patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI). METHODS: This double-blind controlled clinical trial was carried out on 93 diabetic patients (56 males and 37 fe...

Descripción completa

Detalles Bibliográficos
Autores principales: Adel, Seyed Mohammad H., Jorfi, Fateme, Mombeini, Hoda, Rashidi, Homeira, Fazeli, Saad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Saudi Medical Journal 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280595/
https://www.ncbi.nlm.nih.gov/pubmed/35537720
http://dx.doi.org/10.15537/smj.2022.43.5.20220018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280595/
https://www.ncbi.nlm.nih.gov/pubmed/35537720
http://dx.doi.org/10.15537/smj.2022.43.5.20220018

Ejemplares similares